Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · FORTIS

FORTIS

HealthcareHealthcare Services₹60170 cr market cap
₹798.30 ▲ +0.6% today As of 19 Nov 2026
52-week low ₹712.9052-week high ₹990.35

-19.9% from the 52-week high · +11.3% above the low

Fortis Healthcare Ltd. engages in the provision of healthcare delivery services through its subsidiaries. The company is headquartered in Gurgaon, Haryana and currently employs 2,975 full-time employees. The company went IPO on 2007-05-09. The firm is primarily engaged in the business of healthcare services. The company operates through two segments: Healthcare and Diagnostics. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics and ophthalmology, among others. The company manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics and day care specialty facilities. The company has approximately 36 healthcare facilities, including projects under development, 4000 operational beds and over 400 diagnostics centers. The company operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Healthstaff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.

The short version. FORTIS reported revenue of ₹2,735 crore for Sep 2026, up 17.3% from a year earlier. Net profit was ₹312 crore (down 3.1% year on year). Return on equity was 10.5% in Mar 2026. Promoter holding was 31.17% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

FORTIS trades 19.9% below its 52-week high and 11.3% above its 52-week low.

Change over period: —

1M+7.6%
3M-12.9%
6M-18.6%
1Y-14.5%

2 · The business

Is it growing?

Sales, year on year+17.3%

Sep 2026 revenue of ₹2,735 cr.

Profit, year on year-3.1%

Sep 2026 net profit of ₹312 cr.

Net margin11.4%

2.4 pts lower than a year earlier.

3-year growth20.9% profit

Revenue compounded at 13.0% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue27352545236522652331216720071928
Net profit312266266194322260184248
Net margin %11.410.511.28.613.812.09.212.9
EPS (₹)4.143.533.522.574.263.452.443.28

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue91287783689362985718403046324469
Net profit1042774599589555-11058-299
Net margin %11.49.98.79.39.7-2.71.3-6.7
EPS (₹)13.810.267.937.87.35-1.450.77-3.96

3 · The quality

How well does it turn capital into profit?

Return on equity was 10.5% in Mar 2026; debt to equity is 0.29.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %10.58.77.88.1
Return on capital %12.09.89.78.3
EBITDA margin %23.019.919.119.4
Net margin %11.39.98.69.3

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR13.0%17.6%
Profit CAGR20.9%—
Debt to equity0.29
Interest cover5.3x
Current ratio0.86
P/E ratio58.2

4 · The owners

Who holds it, and are they adding?

Promoter holding31.17%

Unchanged over 8 quarters.

Foreign institutions23.19%

Down 3.58 pts over 8 quarters.

Domestic institutions34.46%

Up 4.41 pts over 8 quarters.

Mutual fund schemes273

+54 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter31.1731.1731.1731.1731.1731.1731.1731.170.0
FII26.7727.427.1727.927.8425.9725.223.19-3.58
DII30.0529.4629.7929.1429.3331.3532.2334.46+4.41
Public12.0111.9711.8711.7911.6711.5111.411.18-0.83

Mutual fund holdings · Oct 2026

273 schemes hold this stock

219 the month before.

  • Groww BSE Hospitals ETF18.49% of NAV
  • TATA NIFTY MIDSMALL HEALTHCARE INDEX FUND6.03% of NAV
  • Motilal Oswal Nifty MidSmall Healthcare Index Fund6.02% of NAV
  • Motilal Oswal Nifty MidSmall India Consumption Index Fund4.26% of NAV
  • Axis Services Opportunities Fund4.18% of NAV
  • Baroda BNP Paribas Health and Wellness Fund4.06% of NAV
  • Nippon India MNC Fund3.9% of NAV
  • LIC MF HEALTHCARE FUND3.87% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for FORTIS are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about FORTIS

What is the FORTIS share price?

FORTIS (FORTIS) last closed at ₹798.30, up 0.6% on the day. Its 52-week range is ₹712.90 to ₹990.35.

What is the market cap of FORTIS?

FORTIS has a market capitalisation of about ₹60,170 crore. Its price-to-earnings ratio is 58.2.

How are FORTIS's latest results?

FORTIS reported revenue of ₹2,735 crore for Sep 2026, up 17.3% from a year earlier. Net profit was ₹312 crore (down 3.1% year on year). Return on equity was 10.5% in Mar 2026. Promoter holding was 31.17% in Sep 2026, up 0.00 points over 8 quarters.

Who owns FORTIS?

As of Sep 2026, shareholding was: Promoter 31.17%, FII 23.19%, DII 34.46%, Public 11.18%.

How many mutual funds hold FORTIS?

273 mutual fund schemes held FORTIS in October 2026. That compares with 219 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 25 Jul 2025 · Final Dividend - Rs. 1
  • 24 Jul 2024 · Final Dividend - Rs. 1
  • 20 Jul 2023 · Final Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.